YUANLI CHEMICAL GROUP CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.7 CNY | +2.15% |
|
+8.28% | -13.93% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,353 | 6,459 | 6,356 | 3,762 | 3,238 | - | - |
| Enterprise Value (EV) 1 | 3,353 | 6,459 | 6,356 | 3,762 | 3,238 | 3,238 | 3,238 |
| P/E ratio | 21.2 x | 17.9 x | 10.9 x | 15.1 x | 12.7 x | 10.3 x | 7.97 x |
| Yield | - | - | 1.6% | - | 2.55% | 3.18% | 3.82% |
| Capitalization / Revenue | - | - | 2.37 x | 1.72 x | 1.37 x | 1.18 x | 0.88 x |
| EV / Revenue | - | - | 2.37 x | 1.72 x | 1.37 x | 1.18 x | 0.88 x |
| EV / EBITDA | - | - | 11.3 x | - | 8.08 x | 6.39 x | 5.13 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | 2.16 x | - | 0.98 x | 0.92 x | 0.85 x |
| Nbr of stocks (in thousands) | 203,930 | 203,930 | 203,930 | 206,259 | 206,252 | - | - |
| Reference price 2 | 16.44 | 31.68 | 31.17 | 18.24 | 15.70 | 15.70 | 15.70 |
| Announcement Date | 4/15/21 | 3/17/22 | 4/17/23 | 4/16/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 2,683 | 2,181 | 2,371 | 2,750 | 3,672 |
| EBITDA 1 | - | - | 562.7 | - | 401 | 507 | 631 |
| EBIT 1 | - | - | 539.1 | 300.8 | 303 | 375 | 483 |
| Operating Margin | - | - | 20.09% | 13.79% | 12.78% | 13.64% | 13.15% |
| Earnings before Tax (EBT) 1 | - | - | 536.6 | 300.7 | 303 | 375 | 483 |
| Net income 1 | 157.8 | 360.1 | 469.3 | 249.7 | 258 | 319 | 411 |
| Net margin | - | - | 17.49% | 11.45% | 10.88% | 11.6% | 11.19% |
| EPS 2 | 0.7750 | 1.769 | 2.860 | 1.210 | 1.240 | 1.530 | 1.970 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | 0.5000 | - | 0.4000 | 0.5000 | 0.6000 |
| Announcement Date | 4/15/21 | 3/17/22 | 4/17/23 | 4/16/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | 15.6% | - | 7.7% | 9% | 10.7% |
| ROA (Net income/ Total Assets) | - | - | 13.2% | - | 6.6% | 7.6% | 9% |
| Assets 1 | - | - | 3,550 | - | 3,909 | 4,197 | 4,567 |
| Book Value Per Share 2 | - | - | 14.40 | - | 16.00 | 17.00 | 18.40 |
| Cash Flow per Share 2 | - | - | 2.250 | - | 1.680 | 1.560 | 1.470 |
| Capex 1 | - | - | 90.8 | - | 555 | 555 | 55 |
| Capex / Sales | - | - | 3.38% | - | 23.4% | 20.18% | 1.5% |
| Announcement Date | 4/15/21 | 3/17/22 | 4/17/23 | 4/16/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.7
CNY
Average target price
19.84
CNY
Spread / Average Target
+26.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.93% | 437M | |
| +11.76% | 63.22B | |
| -3.51% | 46.34B | |
| +13.09% | 39.97B | |
| +17.83% | 25.46B | |
| +8.37% | 18.68B | |
| +1.44% | 17.24B | |
| -20.33% | 15.81B | |
| +0.36% | 14.9B | |
| -12.98% | 13.74B |
- Stock Market
- Equities
- 603217 Stock
- Financials Yuanli Chemical Group Co.,Ltd.
